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Biohazardous waste refers to wastes that are potentially infectious to humans, as well 
as wastes from animal or plant research that could be potentially infectious to these 
organisms, or could alter their genetic selection process. Research resulting in generation 
of biohazardous waste is typically conducted at large, research-based universities. The 
purpose of this study was to examine how 122 universities manage their biohazardous 
waste through a survey of environmental health and safety professionals responsible for 
waste management at these institutions. 
Based on the data colIected from this survey (82.6% response rate), university 
biohazardous waste policies are heavily influenced by state environmental regulations, 
the OSHA Bloodborne Pathogens Standard, and CDCINIH biosafety guidelines. 
Biosafety or hazardous materials professionals are the individuals most likely to be 
responsible for program administration. 
Contaminated wastes, both sharps and non-sharps, are almost exclusively treated as 
biohazardous waste by these institutions if they are a potential infection risk to humans. 
They are also likely to be treated as biohazardous waste if they are an infection risk for 
animals but less likely to be treated in this manner if they are a potential infection risk for 
plants. 
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Chapter 1 

INTRODUCTION 
Background 
Biohazardous waste is a term for waste that poses a biological hazard to living 
organisms.  It encompasses medical waste, that primarily refers to wastes that are 
potentially infectious to humans, as well as wastes from animal or plant research that 
could be potentially infectious to these organisms, or alter their natural genetic selection 
process. Research that results in generation of biohazardous waste is commonly 
conducted at large, research-based universities. Management of the biohazardous waste 
stream in this environment is a challenge to the health and safety professional who must 
consider multiple state and federal regulations, as well as understand the nature of 
research being conducted.  Medical waste management guidelines alone do not meet the 
needs of these health and safety professionals.  Studies regarding biohazardous waste 
management in this unique environment are warranted. 
Improper management of biohazardous or potentially infectious waste came to light 
as a public health concern during the summer of 1988 when wash-ups of medical waste 
occurred along beaches of the Atlantic coast and Great Lakes.  At that time, the U.S. 
Congress responded by enacting an interim standard and the Medical Waste Tracking Act 
(MWTA), a two-year demonstration program administered by the U. S. Environmental 
Protection Agency (EPA).  The goals of the Act were to define medical waste, establish a 
tracking system in order to determine the size and origin of the waste stream in four 
states, and to define management practices. 
The Act also required that the Agency for Toxic Substances and Disease Registry 
(ATSDR) conduct a comprehensive study of the role that medical waste may play in 
human infection and disease.  The ATSDR released its report in  1990 and in short, 
concluded that the general public's health is not likely to be adversely affected by medical 
waste in the traditional health care setting.  However, occupational health concerns do 2 
exist for workers involved with handling medical waste.  The ATSDR did note a number 
of limitations regarding the accuracy and availability of occupational exposure 
information collected for various high risk groups such as refuse workers, janitorial and 
laundry workers and laboratory workers.  Another limitation was the lack of available 
information regarding waste generators-who they are and how much waste they generate 
(Turnberg, 1996). 
The MWTA was part of a two-year interim standard that expired in  199I and was not 
reauthorized by Congress (Turn berg, 1996).  However, 43 states have adopted their own 
standards for dealing with this waste stream modeled after this standard (Infectious 
Wastes News, 1998).  State regulations can be more, but not less, stringent than federal 
standards.  This means that even though state programs may have been modeled after the 
federal standard, they can be more restrictive in their definition of medical waste (or 
whatever term they adopt to call the waste stream) and requirements for treatment and 
disposal. 
The issue of defining biohazardous waste becomes more cumbersome when other 
federal agencies and accreditation organizations are considered.  For example, the 
Bloodborne Pathogens standard, codified at 29 CFR1910.1030, and administered under 
the Occupational Safety and Health Administration (OSHA) addresses biohazardous 
waste handling and disposal.  Although OSHA's definitions and practices are likely to 
overlap with state regulations, they are not all inclusive.  OSHA addressed this by 
deferring the employer "to the applicable territorial, state, or local medical waste disposal 
requirements within those jurisdictions, should they exist".  Accreditation agencies such 
as the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) also 
have requirements for defining and managing biohazardous waste, which are likely to 
overlap and possibly be more restrictive than state regulations (Turnberg, 1996). 
The definition of biohazardous waste extends beyond wastes that are potentially 
infectious to humans.  This is especially true for research involving the use of infectious 
agents and recombinant DNA.  When research involves agents or genetically-modified 
organisms that could pose a threat to animals, plants or humans outside of the laboratory 
environment, the researcher must comply with biological waste treatment requirements 
outlined by United States Department of Agriculture (USDA) protocols and/or the 
National Institutes of Health (NIH) Guidelines for Research Involving Recombinant 
DNA Molecules (NIH, 1999).  These treatment requirements are based on the principles 3 
of biological safety containment.  In short, exotic or infectious agents, or items 
contaminated with these materials, must be rendered biologically-inactive prior to 
disposal so that they are not inadvertently released to the environment.  Wastes generated 
in these research environments must therefore be handled in the same manner as wastes 
generated in the clinical environment (i.e. medical waste). 
Problem Statement 
Proper management of biohazardous waste is essential for all generators of this waste 
stream in order to comply with regulatory requirements and meet accreditation criteria. 
Additionally, proper biohazardous waste management is essential to ward off public 
relations issues (such as the 1988 beach washups) and assure the safety of all persons 
who may come in contact with this waste between the point of generation and final 
disposal.  A waste management plan is a tool that can be used to address all of these 
needs. 
Based on the recommendations of the Council of State Governments (1992), a 
biohazardous waste management plan must address: 
- personnel responsibilities 
- definition of biohazardous waste 
- procedures for waste segregation, packaging, storage and transportation 
- treatment methods and monitoring of these methods 
- disposal methods and facilities to be used 
- contingency planning and spill response 
- staff training and safety 
- monitoring of program effectiveness such as inspections and recordkeeping 
Biohazardous waste management plans may be implemented and monitored 
efficiently and effectively in hospital and clinical environments where waste generation 
occurs in a centralized location.  In addition, these environments may have staff who deal 
specifically with the treatment and disposal of the waste stream because it is highly 
visible and regulated in this setting.  In the large, research-based university setting such a 
plan is not easily administered.  Such universities are likely to have facilities located 
throughout a campus, as well as satellite locations off-campus.  If a centralized collection, 4 
treatment and disposal program is not in place, each generator is left with the 
responsibility of properly treating and disposing of their biohazardous waste.  In order to 
assure that this occurs, a strong biohazardous waste training program must be 
implemented and reinforced through equipment validation, on-site inspections and audits 
of equipment and waste disposal records. 
Based on personal experience as an environmental health and safety (EHS) 
professional in  the academic environment, academic regulatory compliance remains to be 
a "hard sell" in the research environment.  Many researchers were working in the lab 
prior to the enactment of regulations for the safe use and disposal of hazardous chemical 
or biological materials.  They can be apprehensive about EHS personnel "telling them 
how they should run their labs".  This mind set establishes a barrier for the reliance on 
principal investigators to assure that biohazardous waste is managed properly at the lab 
level. 
Purpose of the Study and Research Questions 
Environmental health and safety officers are often charged with the responsibility of 
assuring proper biohazardous waste disposal campus-wide.  This is a tremendous 
challenge in an environment where several kinds of research may be generating 
biohazardous waste, depending on the nature of the specific project.  For example, a plant 
used in one project may be thrown in the trash.  The same kind of plant used in a 
recombinant DNA application may have to be treated as biohazardous waste to render it 
biologically-inactive.  Clearly, the federal definition of medical waste, and the guidelines 
for developing a medical waste management plan (designed primarily for the health care 
setting) do not meet the needs of the large research-based university.  The purpose of this 
study is to identify how such universities are addressing this issue through a survey of the 
EHS professionals involved with biohazardous waste management at these institutions. 
The guiding questions on which the survey and study was based are: 
I.  Which agency regulations or guidelines do large, research-based universities 
follow to define their biohazardous waste stream? 

State 

Federal funding agency (i.e. USDA, NIH) 

Accreditation agency (i.e. JCAHO) 
5 
2. 	 What are the most common methods of treatment and disposal for various 
categories of biohazardous waste produced by large, research-based universities? 
What are the categories of waste? 
On-site or off-site treatment? 
Incineration use? 
Use of autoclaves and other means of decontamination? 
3. 	 What administrative controls are used to assure safe and proper handling, 
treatment and disposal of biohazardous waste? 
Who is responsible for the biohazardous waste management program? 
What are the requirements for the waste generators (waste tracking, training, 
equipment logs, etc.)? 
What controls are used to assure compliance with policies (inspections, audits, 
equipment validation, etc.)? 
4. 	 Based on the data collected in # I through #3, what recommendations can be made 
to develop an effective model biohazardous waste management plan for research­
based universities? 
Significance of the Study 
This study is significant because management of the biohazardous waste stream in the 
large, research-based university environment has been virtually unexamined to date.  The 
data generated from this study will provide university EHS professionals with valuable 
information regarding the definitions and management practices that are currently used 
by other large, research-based universities.  It will also provide guidance to university 
EHS personnel who are in the process of developing medical waste disposal policies and 
biosafety programs. 6 
Limitations of the Study 
The results of this survey can only be applied to large, research-based university 
settings.  Results will provide information regarding biohazardous waste management, 
but not management of other forms of hazardous waste. 
Based on the data collected in this study, recommendations for effective program 
development will be presented.  This information may serve as a guide for all universities 
that are in the process of developing biohazardous waste management programs. 
Definitions 
Biohazardous waste: waste that poses a biological hazard to living organisms.  It 
encompasses medical waste, as well as wastes from animal or plant research that could be 
potentially infectious to these organisms, or alter their natural genetic selection process. 
Incineration:  a means of treating and destroying waste by introducing the waste into a 
combustion chamber where it is burned at temperatures between 1400" and 2000"  F. 
Infectious a£!ent:  a disease-causing organism that is sufficiently virulent so that if a 
susceptible host is exposed to it in adequate concentration and through a portal of entry, 
transmission of disease could result. 
Medical waste:  any solid waste that is generated in the diagnosis, treatment, or 
immunization of human beings or animals; in  research pertaining thereto; or in the 
production or testing of biologicals (EPA definition). 
Other Potentially Infectious Materials (OPIM):  human body fluids capable of 
transmitting a bloodborne pathogen (HlV, hepatitis B virus, hepatitis C virus).  These 
fluids include human blood products, semen, vaginal secretions, fluids from the spine, 
lungs and joints, saliva in dental settings and breast milk (OSHA definition). 
Pathological waste: tissues, organs, body parts and body fluids generated through surgical 
or autopsy procedures. 7 
Recombinant DNA molecules:  molecules that are constructed outside living cells by 
joining natural or synthetic DNA segments to DNA molecules that replicate in a living 
cell, or molecules that result from the replication of those described formerly  (NIH 
definition). 
Sharps: an item that is sharp enough to penetrate the skin and is contaminated with 
potentially infectious material.  Examples: needles, scalpels, glass pipettes, microscopy 
slides. 
Sterilization by autoclave: a treatment method where waste is placed in a chamber and is 
treated for at  least 45 minutes at a temperature of at least 12)  C.  This temperature is 
typically achieved through pressurization of the treatment chamber. 
Abbreviations/Acronyms 
AAALAC:  Association For Assessment and Accreditation of Laboratory Animal Care 
APHIS:  Animal and Plant Health Inspection Service 
ATSDR:  Agency for Toxic Substances and Disease Registry 
BSO:  Biological Safety Officer 
BL:  Biosafety Level 
CAA:  Clean Air Act 
CDC:  Centers for Disease Control 
CFR:  Code of Federal Regulations 
DNA:  Deoxyribonucleic acid 
DOT:  Department of Transportation 
EHS:  Environmental Health and Safety 
EPA:  Environmental Protection Agency 
HMIWI:  Hospital/medical/infectious waste incinerator 
JCAHO:  Joint Commission on Accreditation of Healthcare Organizations 
NIH:  National Institutes of Health 
OPIM:  Other potentially infectious materials as defined by the OSHA Bloodborne 
Pathogens Standard 8 
OSHA:  Occupational Safety and Health Administration 
USDA:  United State Department of Agriculture 9 
CHAPTER 2 
LITERATURE REVIEW 
This chapter will review the concepts behind biohazardous waste management 
practices and regulations and guidelines that must be considered in developing waste 
management procedures.  Additionally, research studies and current events related to the 
research topic are presented. 
General Biohazardous Waste Management Practices 
Biohazardous waste management practices begin at the point of waste generation. 
These wastes must be segregated from other wastes and packaged in a manner that limits 
further personnel contact with the contaminated material.  For example, sharps are 
deposited in a labeled, puncture-resistant, closable container to eliminate any further 
puncture hazard presented by such items.  Solid, non-sharps wastes are stored in  sturdy, 
labeled or color-coded bags that are resistant to leaks and punctures.  While these bags 
are in  use, they are typically stored in sturdy, leakproof, labeled trash containers with lids 
to reduce personnel exposure risk.  These segregation and handling practices are outlined 
consistently in  several regulations and guidance documents including the EPA Guidefor 
b~l('cti()us Waste Management (1986) and OSHA's Bloodborne Pathogens standard as a 
means of protecting personnel who may encounter the waste. 
Treatment of biohazardous waste may be performed on-site or sent off-site through a 
waste hauler or centralized waste management program.  On-site treatment requires 
additional handling of wastes and therefore more opportunities for exposure.  Treatment 
methods may include incineration, autoclaving, sewer discharge and alternative treatment 
technologies such as microwave or chemical disinfection. 10 
Incineration is ideal for treatment of pathological wastes and anatomical parts, and is 
an effective means of reducing waste volume (AWMA Medical Waste Committee, 
1994).  However, this treatment option has fallen out of favor in  recent years due to the 
costs associated with more stringent air emission requirements and public health concerns 
regarding dioxins and other pollutants released through this process. 
Sterilization by autoclave is an effective means of decontaminating biohazardous 
waste under the appropriate operating conditions.  This method may be used for nonsharp 
solid wastes such as contaminated plasticware and gloves.  Autoclaving is an accessible 
means of on-site treatment in most lab environments.  However, the method requires a 
long cycle time (usually in excess of 45 minutes), surveillance of equipment operating 
parameters, and is restrictive to relatively small quantities of waste in order to effectively 
decontaminate the load (Turnberg, 1996).  Once decontaminated, waste may be 
landfilled as nonhazardous waste in some states (b~fectious Wastes News, 1998).  The 
question of effective decontamination is an issue that needs to be addressed through 
performance testing.  Autoclave tape is commonly added to articles to be treated to verify 
that the required temperature has been achieved during the cycle.  Chemical indicator 
strips may be used for the same purpose.  However, these methods are generally only 
reliable as temperature indicators.  A biological indicator, Bacillus stearothermophilus, is 
the recommended method for verifying that the autoclave is operating effectively for 
biohazardous waste treatment (Council of State Governments, 1992).  In this test method, 
a heat-tolerant microorganism (B.  stearothermoplzilus) is exposed to the autoclave 
treatment conditions and is then incubated to determine if the organism was deactivated 
to an  acceptable level. 
Incineration and autoclave sterilization are the two most commonly used techniques 
for treating biohazardous waste (Cross, 1990).  Sewer discharge may be used as a 
disposal technique but is limited to primarily human blood and body fluids.  Chemical 
disinfection of wastes may also be used.  On a small scale, this process may be carried 
out at the point of generation and involves treating the waste liquid or materials with a 
disinfectant such as bleach solution in order to inactivate the biological contaminants of 11 
these materials prior to disposal.  On a large scale, this process could involve a stand­
alone treatment unit specifically designed to treat hundreds of pounds of waste in a short 
period of time.  Chemical disinfection on this scale is an example of an alternative 
treatment technology, meaning large-scale treatment process without using incineration. 
Alternative treatment technologies are growing in popularity.  Many alternative 
treatment system manufacturers claim that these emerging technologies are an effective 
means for treating virtually all forms of biohazardous waste and can significantly reduce 
the final volume of the waste.  At this time, such technologies are primarily used by large 
hospitals and waste haulers because the expense of such units is cost-prohibitive for most 
waste generators as a form of on-site treatment (Turn berg, 1996). 
Regulations and Guidelines 
Federal Environmental Regulations 
Federal environmental regulation of biohazardous waste began after the Resource 
Conservation and Recovery Act (RCRA) of 1976 went into effect. This Act defined 
hazardous wastes and specified requirements for the handling and disposal of such 
wastes.  Subtitle C of the Act required the EPA to develop and promulgate regulations for 
the identification of characteristics of hazardous waste.  Infectiousness was, at that time, 
included as a waste criterion.  However, when final hazardous waste mles were published 
in  1980, EPA had omitted the previously proposed infectious waste standards (Turnberg, 
1996). 
Although the EPA excluded infectious waste from its hazardous waste regulations, it 
released a guidance document in  1986 addressing the waste stream.  This document 
entitled. EPA Guide for b~f'ectious Waste Management provides information regarding 
the definition of infectious waste and acceptable infectious waste management practices 
including recommendations for an infectious waste management plan and specific 12 
treatment methods for the different types of infectious waste.  The definitions and 
recommendations contained in this document served as the basis for many state level 
infectious waste regulations and therefore are summarized below. 
In  this guidance document, the EPA defines infectious waste as "waste capable of 
producing infectious disease", but notes that consideration must be given to the factors 
necessary for disease transmission including the presence of a virulent pathogen, dose, 
portal of entry, and host susceptibility (EPA, 1986).  Therefore a risk assessment 
performed by a responsible authorized person may be required to truly define infectious 
waste.  Nonetheless, EPA did define categories of infectious waste and provide examples 
as listed in the table on the following page. 13 
Table 1:  EPA Infectious Waste Categories' 
Waste Category  Examples 
Isolation wastes  •  EPA referred to CDC's Guidelines for Isolation 
Precautions in Hospitals (latest version, 1996) 
Cultures and stocks of infectious  •  Specimens from medical and pathology 
agents and associated biologicals  Iaboratori  es 
•  Cultures and stocks of infectious agents from 
clinical, research, and industrial laboratories; 
disposable culture dishes, and devices used to 
transfer, inoculate and mix culture 
•  Wastes from production of biologicals 
•  Discarded live and attenuated vaccines 
Human blood and blood 
products 
•  Waste blood, serum, plasma, and blood products 
Pathological Waste  •  Tissues, organs, body parts, blood, and body 
fluids removed during surgery, autopsy and 
biopsy 
Contaminated sharps  •  Contaminated hypodermic needles, syringes, 
scalpel blades, Pasteur pipettes, and broken 
glass 
Contaminated animal carcasses, 
body parts. and bedding 
•  Contaminated animal carcasses, body parts, and 
bedding of animals that were intentionally 
exposed to pathogens 
Miscellaneous contaminated  •  Wastes from surgery or autopsy (i.e. soiled 
wastes (may be infectious under  dressings, sponges, drapes, etc.) 
certain conditions) 
Miscellaneous laboratory wastes (i.e. specimen  • 
containers, slides and cover slips, disposable 
gloves, etc.) 
•  Dialysis unit wastes (i.e. tubing, filters, 
disposable sheets, etc.) 
•  Contaminated equipment used in patient care, 
laboratories or research. 
'1llfimll{ltioll adaJltedfi'om EPA Guide(or b!(ectiou.I' Waste Management.  1986 14 
The EPA Guide (1986) also recommended that facilities appoint a responsible person 
or committee to prepare an infectious waste management plan that included definition of 
infectious waste, procedures for the management of waste from the point of generation 
through disposal, contingency planning and staff training.  Additionally, the EPA made 
specific treatment recommendations for the treatment and disposal of each waste 
category. 
Isolation wastes, such as contaminated solid items from patient care, should be steam 
sterilized or autoclaved.  Liquid isolation wastes, such as urine and feces, should be 
discharged to the sanitary sewer within the patient care unit if possible.  The EPA 
recommended that cultures and stocks be steam sterilized on site if a sterilizer was 
available.  Incineration and thermal inactivation were listed as acceptable alternatives. 
Steam sterilization and incineration were recommended by the EPA for treating 
human blood and blood products when possible.  Discharge to the sanitary sewer was 
listed as an  acceptable alternative.  Pathological waste should be incinerated whenever 
possible due in  part to aesthetics.  Steam sterilization, followed by grinding and discharge 
to the sanitary sewer was listed as  an  alternative. 
The EPA recommended a single uniform management system for all sharps due to the 
inherent puncture hazard of sharp materials.  Sharps should be placed in rigid, puncture­
resistant containers after use.  Both incineration and steam sterilization were 
recommended as treatment methods.  However, in the case of steam sterilization, 
compaction or grinding was suggested to meet state or local regulatory requirements. 
Incineration was the recommended method of treatment for animal carcasses, body 
parts and bedding to both eliminate the infectious hazard as well as the carcass.  Steam 
sterilization was listed as an  alternative for carcasses, but only if the carcass material was 
limited in quantity and was ground up and flushed to the sewer.  Steam sterilization of 
bedding was not recommended.  Regarding miscellaneous wastes, the EPA recommended 
steam sterilization or incineration as effective treatment methods. 15 
Although the EPA guidelines provided a wealth of information about the proper 
management of infectious waste, issues related to the mismanagement of this waste 
stream came to light and forced the EPA to further address the issue.  In the summer of 
1988, there were beach wash-ups of medical waste in 5 states.  Coupled with other 
incidents of illegal dumping of medical waste at that time, the U.S. government reacted 
by enacting the Medical Waste Tracking Act of 1988 (Council of State Governments, 
1992).  The MWTA was an interim standard that was codified at 40CFR259 and 
appeared as Subtitle J under RCRA.  The goals of the Act were to define medical waste, 
establish a tracking system in order to determine the size and origin of the waste stream 
in  four states, and to define management practices. The regulation required regulated 
medical waste generators (those producing in excess of 50 pounds of waste per month) in 
New York. New Jersey, Connecticut, Rhode Island and Puerto Rico to identify, quantify, 
manage, and track (manifest) their waste in a manner similar to other RCRA hazardous 
wastes.  The MWTA expired in  1991  with 2 interim reports, but no final reports as 
required by the Act, generated regarding this waste stream (Turn berg, 1996). 
The treatment and disposal of biohazardous waste is also impacted by air quality 
standards due to the common use of incineration.  The EPA Clean Air Act (CAA) was 
originally passed in  1955 and was intended to address smoky, dirty air in industrial cities. 
Since that time, the CAA was amended in 1970, 1977 and 1990.  The 1990 amendments 
were implemented to put strict controls on  189 hazardous air pollutants using a two-phase 
standard process and requiring emissions generators to install Maximum Achievable 
Control Technology (MACT) to reduce emissions (Cox, 1992). 
In  1997, the Clean Air Act Amendments reached the biohazardous waste generator 
(specifically the medical waste generator) when the EPA promulgated the "Standards for 
Performance for New Stationary Sources and Emission Guidelines for Existing Sources: 
Hospital/Medical/Infectious Waste Incinerators," codified at subpart Ce of 40CFR60. 
Under these regulations, a hospital/medical/infectious waste incinerator (HMIWI) is 
defined as an incinerator whose calendar quarterly waste by weight consists of hospital 16 
and/or medical/infectious waste in a portion of 10% or greater.  Although incinerator 
facilities that burn less than 10% of this waste type on a quarterly basis by weight are 
exempt from the main provisions of the standard, they are still required to file an 
exemption with the appropriate state agency and keep records of the fuels and wastes 
burned. 
Although the HMIWI regulations are a federal statute, the regulation was written in 
such a way as to give states the opportunity to develop their own plans to address the 
provisions of the regulations.  Timeline options are available for the states if increments 
of progress for compliance can be demonstrated.  However, all HMIWI will be subject to 
the federal statute requirements on September 15,2002.  These requirements include: 
emission limits for particulate matter, dioxins and 8 other pollutants, performance testing, 
ongoing parameter monitoring, inspections, operator training, waste management plans, 
reporting and recordkeeping, and a Title V permit (US EPA Region V,  1999). 
There were over 5000 medical waste incinerators in the U.S. in  1996.  It is expected 
that over 80% of these will shut down as the result of the HMIWI regulations (Brunner, 
1996). 
Other Federal Regulations 
With the onset of the HIV epidemic in the U.S. in the late 1980's, the CDC published 
"Recommendations for Prevention of HIV Transmission in Health-Care Settings" to 
address associated infection control issues.  These guidelines included recommendations 
for the handling of infectious wastes in this context.  In  1992, the U.S. Occupational 
Health and Safety Administration (OSHA) enacted the Bloodborne Pathogens standard 
(29CFR 191 0.1 030) based on these guidelines.  The standard defined specific infectious 
wastes and called for specific containment and labeling of these waste types.  The 
standard applies to employees who have a "reasonably anticipated risk of exposure" to 
human blood or OPIM as defined by the standard.  The definition of reasonably 17 
anticipated risk is based on the employer's determination.  Because the standard was 
based on CDC recommendations for the healthcare setting, it was written to address 
occupational exposure primarily in that setting. 
Transportation of infectious waste on public roads is regulated by the U.S. 
Department of Transportation (DOT).  Under this regulation, an infectious substance is 
defined as "a material known to contain, or reasonably expected to contain pathogens." 
Pathogens are defined as "microorganisms or recombinant microorganisms that are 
known or reasonably expected to cause infectious disease in humans or animals" 
(49CFR 173.134). Regulated medical wastes, biological products, and diagnostic 
specimens are included in  the infectious substance definition.  A regulated medical waste 
is defined as "a waste, or reusable material, that contains an infectious substance and is 
generated in  the diagnosis, treatment, or research of humans or animals" and does not 
include discarded cultures or stocks (DOT, 1999).  Infectious substances must be labeled 
for transport with the 6.2 hazard class label.  In addition, specifications for packaging 
must be met to assure that materials are not released during transport.  Packaging 
requirements are listed at 49CFR 173.197 and include capacity limits for single packages 
and net loads and performance specifications for packaging. 
In  August of 1999, the DOT implemented stricter safety standards for the transport of 
regulated medical waste.  These changes are likely to impact medical waste haulers and 
the parties who use this type of service.  In short, the changes included stricter 
specification for the use of plastic bags, bracing of rigid packages to reduce movement 
during transport, segregation of rigid packages from bags when both are placed in roll-off 
bins, and  sign-off by the customer accepting responsibility for packaging (Grinder, 
1999). 
The National Institutes of Health's (NIH) "Guidelines for Research Involving 
Recombinant DNA Molecules" is the most inclusive regulatory document for defining 
biohazardous waste (NIH, 1999).  Compliance with the NIH guidelines is required for all 
parties who receive funding through the NIH and who are conducting recombinant DNA 18 
research.  The NIH guidelines outline containment requirements for various levels of 
research, known as biosafety levels. The levels of research are determined based on the 
nature of the DNA segment to be studies, the application of the study (in vivo or in vitro), 
and the virulence of the microorganisms to be used as vectors or as organisms to be 
altered or used in challenge.  In short, the lower the risk to personnel and the 
environment, the lower the biosafety level.  A biosafety level is comprised of laboratory 
practices and techniques, safety equipment (primary barriers), and facility design 
(secondary barriers).  The NIH guidelines define the requirements for each of these 
components as well as refer readers to the CDC/NIH Biosafety in Microbiological and 
Biol1ledical La/Joratories (1999) for further guidance.  Unlike other federal documents, 
the NIH guidelines do address infectious agents for plants and the waste products 
produced in  those processes.  A summary of waste treatment requirements for plant, 
animal and laboratory biosafety levels (BL)  I through 3 is presented on the following 
page. 19 
TABLE 2: NIH Guidelines Waste-Related Requirements' 
Waste-Related Requirements: Plant Research 
BL 1 
Experimental organisms shall be rendered biologically inactive by appropriate methods 
before disposal outside the greenhouse. 
BL2 
An autoclave shall be available for the treatment of contaminated greenhouse materials. 
BL3 
All waste experimental materials shall be sterilized in an autoclave or rendered 
biologically inactive by appropriate methods before disposal. 
Waste-Related Requirements: Animal Research 
BL 1 
A carcass shall be disposed of in a manner to avoid its use as food for human beings or 
animals unless specifically authorized by an appropriate federal agency. 
BL2 
Contaminated materials that are decontaminated at an off-site location shall be placed in 
a closed durable leakproof container prior to removal from the area. 
Needles and syringes shall be promptly placed in puncture -resistant containers and 
decontaminated, preferably by autoclaving, before discard or reuse. 
An autoclave shall be available for decontamination of laboratory wastes. 
BL3 
Needles and syringes shall be promptly placed in puncture -resistant containers and 
decontaminated, preferably by autoclaving, before discard or reuse. 
Liquid effluent from containment equipment (i.e. sinks, BSCs, animal rooms, f10rr 
drains, sterilizers) must be decontaminated by heat treatment prior to release to the 
sanitary sewer.  Temeprature monitoring must be conducted for this process. Validation 
of effectiveness must be performed with an indicator organism every 30 days. 
All animals shall be euthanized at the end of the experimental usefulness and the 
carcasses decontaminated before disposal in  an appropriate manner. 
Waste-Related Requirements: Laboratory Research 
BL 1 
All contaminated liquid or solid wastes are decontaminated before disposal. 
Contaminated materials that are decontaminated at an off-site location shall be placed in 
a closed durable leakproof container prior to removal from the area. 
BL2 
Same requirements as BL I. Additionally: 
Needles and syringes shall be promptly placed in puncture -resistant containers and 
decontaminated, preferably by autoclaving, before discard or reuse. 
An autoclave for decontaminating waste is available. 
BL3 
Same requirements as BL 2.  Additionally: 
An autoclave for decontaminating lab wastes is available preferably within the lab. 
<
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The U.S. Department of Agriculture's Animal and Plant Health Inspection Service 
(APHIS) also recognizes the principles of biological containment.  One responsibility of 
this agency is the control of importation, interstate shipment and environmental release of 
plant pests.  Under APHIS regulations, a plant pest is defined as: 
"any living stage (including active and dormant forms) of insects, mites, 
nematodes, slugs, snails, protozoa, or other invertebrate animals, bacteria, fungi, 
other parasitic plants or reproductive parts thereof; viruses; or any organisms 
similar to or allied with any of the foregoing; or any infectious agents or 
substances, which can directly or indirectly injure or cause disease in or damage 
to any plant or parts thereof; or any processed, manufactured, or other product of 
plants (7CFR340.1 )." 
This definition includes genetically modified organisms involving plant pests 
listed in  the APHIS regulations.  To conduct research involving plant pests that will 
involve an environmental release (i.e. field trial) or interstate shipment of the item, a 
researcher must obtain a permit through APHIS.  To obtain a permit, the researcher 
must comply with specified APHIS protocols for the proper containment of the pest 
(7CFR340).  Management of the waste is included in these protocols when 
appropriate and usually involves biological inactivation of plant pests prior to 
disposal, similar to NIH Guideline requirements for plant research. 
Accreditation Requirements 
In order to be eligible for certain sources of funding, facilities may need to be 
accredited by an agency associated with their area of operation.  For hospitals and certain 
health care facilities, this accreditation body is the Joint Commission on Accreditation of 
Healthcare Organizations (JCAHO).  The JCAHO has standards manuals that outline 
policies and procedures that must be implemented in order for a facility to receive 
JCAHO accreditation.  Regarding waste management procedures, the JCAHO requires 21 
the facility to have a written plan that includes policies, procedures performance 
standards, written criteria, and goals and objectives of the waste management program. 
Additionally, the program must address any state, local and federal requirements related 
to the management of this waste stream (Turn  berg, 1996). 
The Association for Assessment and Accreditation of Laboratory Animal Care 
(AAALAC) is an agency that accredits facilities where animal research is conducted. 
Like the JCAHO, performance manuals and related documents must be followed by the 
accredited facility.  AAALAC requires facilities seeking accreditation to follow The 
Guide for the Care and Use of Laboratory Animals, published by the National Research 
Council (1989), for the establishment of facility standards.  According to this document, 
hazardous wastes must he rendered safe through sterilization and containment practices. 
Additionally, procedures should be established and integrated into occupational safety 
and health policies specifically addressing on-site packaging, labeling, transportation and 
storage of such wastes. 
State Environmental Regulations 
In  1992, the Council of State Governments produced  Model Guidelinesfor State 
Medical Waste Management.  Using survey information compiled from state agencies 
and national associations, this document was generated as part of the EPA's commitment 
to identify alternative approaches to medical waste management as mandated by the 
MWTA of 1988.  The document was generated to serve as a ready-reference for states 
implementing medical waste regulations, containing information about essential elements 
for waste management programs including: public education, minimization, transport, 
treatment, disposal and worker training. 
In  1998, Waste Age/b~rectious Waste News conducted a medical waste regulatory 
survey that included information from all U.S. States and the District of Columbia. 
Based on this survey, 43 states had specific medical/infectious waste regulations in place 22 
at that time.  Even though most states have regulations in place, the provisions of these 
regulations are highly variable.  For example, 15 states indicated that their regulations 
permitted the landfilling of untreated medical waste.  On the opposite end of the 
spectrum, 16 states indicated that their regulations require medical waste to be rendered 
unrecognizable.  One common provision noted by 29 states was the approval of 
alternative technologies.  This may be the result of more stringent incineration 
regulations at both the state and federal level (US EPA Region V, 1999). 
Related Research 
Based on a literature review using several on-line indexes, no studies were identified 
that specifically addressed biohazardous waste management practices in the large 
research-based university environment.  Perhaps the study most closely related to the 
research presented here is a survey conducted by Klangsin in  1993.  In this study, a 
survey was administered to hospitals in Idaho, Oregon and Washington (Klangsin, 1993). 
The goals of this study were to investigate and compare medical waste practices and 
treatment techniques used by hospitals in  this region.  Because this study was regional in 
nature and specifically addressed hospitals, the results are not relevant to the present 
study.  However, the current study was initiated in part to address one of the 
recommendations of the Klangsin study- the need to examine waste management 
practices in environments beyond the hospital. 
Several studies have been conducted regarding medical waste management practices 
in  the health care environment both nationally and regionally (Klangsin, 1998).  One 
study was conducted in Oklahoma to assess biohazardous waste generation in that state 
(Boatright, 1995) but was not restricted to a specific generation source or industry. 23 
Current Events 
Issues related to the improper treatment and disposal remain unresolved.  An example 
of this is the recent occurrence of medical waste discovered on the shores of New York's 
Rockaway Beach in July of 1998 (NY Times,  1998).  In addition, occupational exposure 
for waste handlers have occurred over the years creating "fear of AIDS" cases.  The New 
Jersey case of Williamso11  v.  Waldman et al is just one of many examples involving waste 
handling personnel who have sustained puncture wounds from sharp items that are 
presumably biologically-contaminated and improperly disposed of (Chenoweth, 1996). 
These issues are related to the handling and disposal practices of this waste stream and 
can only be addressed through strong and vigilant administrative policy.  Perhaps the 
most significant development that is likely to affect the large research-based university is 
the change to incinerator regulations. 
With the implementation of EPA's HMIWI regulations, waste generators as well as 
the public have become aware of the potential adverse health effects associated with 
incinerating medical waste.  One clear example of this occurred in  1999 when a 
Philadelphia hospital and affiliated incinerator operator were fined $250,000 and required 
to conduct a $250,000 asthma screening project for local children after violating CAA 
and state air emission standards (Geiselman, 1999). 
The university environment is already starting to feel the impact of HMIWI 
requirements and public relations issues associated with this practice.  In November of 
1999, the Sf([l~f()rd Daily reported on student protests and plans for educating the 
community about "environmental racism" in regards to Stanford's use of an incinerator 
for disposal of medical waste.  Students opposing incineration are concerned about the 
release of dioxin to low income communities located near the incinerator (Chao, 1999). 
The Minnesota Dai/."r (University of Minnesota) published an article in October of 1998 
regarding medical waste incineration.  Again, the focus of this article was on dioxins 
produced through the incineration process.  Alternatives to incineration and actions to be 
taken on the part of the medical facilities associated with that university were highlighted 24 
as well (Huiras, 1998).  Based on these recent articles, it is evident that the university 
community is becoming more aware of the health implications related to incineration and 
are likely to oppose ongoing use of incineration as a means of treating biohazardous 
waste. 25 
CHAPTER 3 
METHODS 
To answer the research questions proposed in this thesis, a survey was administrated 
to environmental health and safety professionals employed by large, research-based 
universities in the United States. 
Sample Population and Selection of Subjects 
The sample population for this study was universities that have been classified by the 
Carnegie Foundation for the Advancement of Teaching as Research I and Research II 
universities.  Research I universities are defined as giving high priority to research and 
receiving $40 million or more annually in federal funding.  There are currently 88 
universities in  this classification (see Appendix A).  Research II universities are also 
defined as giving high priority to research but receiving between $15.5 million and $40 
million annually in  federal funding.  There are currently 34 universities in  this 
classification for a total sample population of 122 (see Appendix A).  This population 
was selected because these universities are most likely to be conducting research in areas 
such as microbiology, biochemistry or animal science where the generation of medical or 
hiohazardous waste outside of the clinical environment is likely to occur.  Additionally, 
these universities are likely to have an environmental health and safety staff who are 
knowledgeable of, and possibly responsible for, the administration of the university's 
program for managing medical waste. 
Survey respondents were selected based on information solicited from the 
universities' environmental health and safety department.  Each university's EHS 
department was contacted by phone to identify the appropriate person to complete the 
survey.  Once identified, the potential respondent was contacted by phone to verify that 
they were indeed the best person to complete the survey, as well as to introduce myself, 26 
provide an overview of the survey and its significance, and verify mailing information. 
This first contact with respondents was done in accordance with OSU Institutional 
Review Board requirements (see Appendix B). 
Survey Instrument 
A questionnaire sent by mail was used as the survey instrument for this study (see 
Appendix C).  Based on principles from Salant and Dillman's (1994) How To  Conduct 
YOllr OWIl Survey,  the questionnaire was designed to attract the interest of the respondent, 
and be simple to complete for the respondent. 
The questionnaire was 4 pages, printed on the front and back on standard 8 '/2 " x  11" 
white paper, stapled twice down the left-hand side bookstyle.  Times New Roman font 
was used for the text of the instrument, with 10 to 12 point font used for the body of the 
questionnaire. 
The first page was used as a cover.  To grasp the attention of the respondent, the 
cover included the title of the study. a graphic design to further identify the study (in this 
case, the biohazard logo), the name of the study's sponsor, and the return address.  The 
back of this page was used as a respondent reference page and included a brief 
instructions summary and operating definitions (see Appendix C). 
The following 2 Y2  pages of the questionnaire contained 17 questions based on the 
research questions previously stated.  The questions were categorized and presented in 
the order that they appeared in  the cover letter introducing the survey.  To further guide 
respondents, the category was listed in bold print at the beginning of each set of questions 
in  that category.  Questions were designed to be closed-ended and exhaustive when 
possible.  This was achieved through listing options for each question, including an 
"other" option for write-in responses, and asking the respondent to circle or check the 
appropriate response.  All questions using this format were limited to 6 options to 27 
minimize the possibility of category order effect whereby the respondent may be 
influenced to pick the first option if the list of options is substantial.  An example of this 
format is demonstrated below: 
3. 	 Who has primary responsibility for the development and maintenance of your 
institution's biohazardous waste management procedures? (Please check one box.) 
o 	 Biological Safety Officer 
o 	 Biological Safety Committee 
o 	 Hazardous Waste Specialist 
o 	 Other:__________________ 
(Please write in response ~lapplicable.) 
In some instances, similar items were grouped together in  a table format to reduce the 
number of individual questions and expedite completion of the survey for the respondent. 
An example of this format is demonstrated below: 
I. 	 Which agency definitions, guidelines or regulations were used to develop your 
institution's biohazardous waste management procedures? (Please circle NO or 
YES/or all categories.) 
Agency 
a.  EPA Regulations (e.g. Medical Waste Tracking Act)  NO  YES 
b.  Local Waste Regulations (e.g. Publicly Owned Treatment 
Works) 
NO  YES 
c.  State Waste Regulations  NO  YES 
d.  OSHA Regulations (e.g. Bloodbome Pathogens Standard)  NO  YES 
e.  CDC/NIH Guidelines (e.g."Biosafety in Microbiological and 
Biomedical Laboratories") 
NO  YES 
f.  USDA/APHIS Regulations (e.g. "Introduction of Regulated 
Articles"; 7CFR340) 
NO  YES 
(T  Accreditation Agency Requirements (e.g. JCAHO, AAALAC) /:"  NO  YES 
h.  USDOT Regulations (e.g.49CFR171-180)  NO  YES 
I.  Other: 
(Please write in response ifapplicable.) 
NO  YES 28 
Not all questions were applicable to all respondents, such as questions pertaining to 
autoclave use and surveillance.  In  these instances, instructions were added to the 
response option to guide respondents to the next applicable question. 
The back side of the final page was used as a back cover for the questionnaire.  This 
page included a large box for written comments, an acknowledgment of participation, and 
the return address for the questionnaire. 
Validity and Reliability of the Instrument 
Several steps were involved in establishing the validity and reliability of the 
questionnaire before the survey was distributed for data collection.  The initial draft of 
the questionnaire was submitted to 10 colleagues and professionals in the public health 
and EHS fields for comment on the content and layout of the questions.  Based on initial 
response, revisions were made, and the questionnaire was resubmitted to the same group 
for further comment.  After final revisions of the initial survey, a pilot test was conducted 
to establish validity and reliability.  The pilot test was conducted after the initial survey 
and research plan was reviewed and approved by the OSU Institutional Review Board. 
The pilot test was conducted using principles from the Portney and Watkins (1993), 
Foundations of  Clinical Research: Applications to Practice.  In  an ideal pilot test 
situation, a pilot group will consist of individuals who are part of the population being 
sampled.  Because the survey population used in this study was actually a census 
population (not a sample population) of individuals who are most knowledgeable and 
responsible for biohazardous waste management at their institutions, an alternative form 
of pilot group was used.  The pilot group consisted of 5 EHS professionals who worked 
for institutions to be surveyed, and who were knowledgeable of their institution's 
biohazardous waste procedures, but they were not primarily responsible for biohazardous 
waste programs. 29 
The survey was mailed to the pilot group with a request to complete and return it 
within two weeks.  All surveys were returned within that time frame.  One week later, the 
survey was again sent to the pilot group with the same instructions.  Responses were 
again returned within two weeks.  This two-time administration over a one month period 
was used to establish reliability of the instrument.  Based on the comparison of the two 
surveys, reliability was questionable for certain parts of the final question on the survey. 
The challenge to the reliability of this question was likely due to the position of the 
question in the survey, and the fact that the question had 11  items that contained 
overlapping concepts.  Responder fatigue was a likely factor under these circumstances. 
To address this in the final questionnaire, the question was rewritten and reduced to 7 
items and was moved up in the questionnaire.  Comments regarding question clarity were 
also incorporated into the final questionnaire (See Appendix C). 
Administration of the Survey 
The administration of the survey began with a mailing in early September 1999. 
Respondents were mailed a survey packet that included: 
a cover letter explaining the goals of this study, instructions for completing the 
and returning the survey, and researcher contact information 
a questionnaire; and 
a self-addressed stamped return envelope. 
To assure that responses were received, a post office box was secured for the duration 
of the study.  Respondents were asked to return their completed survey within 30 days. 
After the 30-day period, non-responders were contacted via electronic mail or by phone 
to remind them of the survey.  Completed questionnaires were accepted until December 
15,  1999 for inclusion in the data analysis. 30 
Data Analysis 
Upon receipt of a completed survey, identification numbers from the back of the 
survey were recorded for follow-up purposes and then removed.  Nex t, the survey was 
reviewed for completion.  If the survey was complete for at least 14 of the 17 questions, it 
was included in the data entry and analysis.  This minimum criteria reflects an  80% 
completion of the survey questions.  It was used to eliminate surveys that were likely to 
be invalid, where the respondent was not attentive to the instructions or content of the 
survey. 
Survey responses were numerically coded for data entry.  Where appropriate, "YES" 
responses were coded as a "1" and "NO" responses were coded as a "0".  For questions 
asking the respondent to check the appropriate category, options were numerically coded 
"1", "2", "3", etc. depending on the number of options.  All data was entered and 
analyzed by the graduate candidate using the Microsoft Excel 2000 spreadsheet program. 
The entered data was reviewed twice to assure that data entry criteria was consistent and 
free from error. 31 
CHAPTER 4 
RESULTS 
Of the 122 research institutions solicited, 121  agreed to participate in the survey. 
Upon termination of data collection in December of 1999, 102 surveys had been returned. 
Two of these surveys were discarded due to lack of completion (less than 14 questions 
answered).  The total number usable responses was 100 for an overall response rate of 
82.6%.  Of the 100 respondents, 71  were from Research Classification I institutions for 
an  81.6% response rate from this group.  Twenty-nine respondents were from Research 
Classification II institutions, for an  85.3% response rate from this group. 
To rule out attrition effects, information was solicited (via electronic mail) from 6 
non-responders regarding why they had not completed the survey. Two individuals 
responded.  One indicated that the survey had been completed and passed on for mailing 
and may have gotten lost.  The other individual indicated that the biosafety department at 
that particular institution was fairly new and that development of uniform policies was 
currently underway.  Therefore, she was unsure how to respond to some of the survey 
questions and chose not to respond.  Based on this limited feedback and the closeness of 
the response rates between the two Research Classifications, attrition was an unlikely 
source of error in  this study. 32 
Institutional Profile 
Information about the kinds of activities and/or facilities that the institution had that 
would be likely to impact biohazardous waste generation are shown in Figure 1. 
FIGURE 1: Institutional Activities and Facilities 
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The response rate for this question was 99% to 100%, depending on the activity 
category in question.  Forty-three percent of respondents indicated that their institution 
had an  in-patient medical treatment (He) facility.  Thirty-four percent indicated that their 
institution had a veterinary medicine school that performs teaching, treatment and 
research .  All respondents (100%) indicated that biotechnology research is conducted at 
their institution, while 97% indicated that BL2 research was being conducted at their 33 
institution.  Sixty percent of respondents indicated that their institution has a BL3 facility 
that is currently in use. 
Biohazardous Waste Management Procedure Development 
Two questions in the survey assessed what regulations or guidelines were used to 
develop biohazardous waste management policies and who is responsible for the 
development of those policies. 
FIGURE 2: Regulations and Guidelines Used to Develop Policies 
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The total response rate for the categories in this question ranged from 87% (for the 
USDOT category) to 97% (for the OSHA category).  Percentages for each category, as 
demonstrated in Figure 2 were determined based on total number of respondents for that 
particular category.  Sixty-three percent of respondents indicated that EPA regulations 
(i.e. MWTA) had been used as a basis for their policies.  Sixty-four percent indicated that 34 
local regulations were used while 98% indicated that state regulations were used.  OSHA 
regulations were cited by 93% of respondents.  Eighty-six percent of respondents 
indicated that CDC/NIH guidelines were used in the development of policies.  Forty-nine 
percent indicated that USDNAPHIS requirements were used.  Accreditation agency 
requirements were cited by 61 % of respondents and USDOT requirements were cited by 
69% of respondents.  Five respondents also listed other regulatory requirements including 
state agricultural regulations, state health codes and Nuclear Regulatory Commission 
requirements. 
Information was gathered on who has the responsibility for biohazardous waste 
management policy development in the large research-based university environment as 
shown in Figure 3. 
FIGURE 3: Personnel Responsible for Biohazardous Waste Management 
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The response rate for this question was 99%.  The Biosafety Officer was the most 
frequently designated responsible individual for 40% of the institutions.  The Biosafety 
Committee was cited as the responsible body at 12% of the institutions.  Nineteen percent 
of respondents indicated that the Hazardous Waste Specialist was the responsible 
individual. 35 
Twenty-nine percent of respondents indicated that other individuals were responsible 
for the biohazardous waste management policies.  Nine of these responses indicated that 
it was a responsibility for environmental affairs or environmental health and safety 
personnel.  Four listed safety professionals as the responsible individual. Two institutions 
indicated that it was the responsibility of the individual departments, and the remainder of 
respondents noted a joint responsibility between safety committees and EHS 
professionals. 
Defining Biohazardous Waste 
Questions were asked in the survey regarding what items institutions consider to be 
biohazardous waste and under what conditions.  Respondents were first asked to indicate 
which non-sharp solid waste items commonly found in the research environment are 
treated and disposed of as biohazardous waste.  Items were broken down into 5 categories 
which were: cultures and stocks of infectious agents (category 1), cell cultures (category 
2), human tissues and body fluids (category 3), animal research and diagnostic wastes 
(category 4), and plant materials (category 5). 
FIGURE 4: Treatment and Disposal of Cultures and Stocks 
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The response rate for this question was 97% to 100%, depending on the category in 
question.  Regarding cultures and stocks of infectious agents (and items contaminated 
with such materials), 100% of respondents indicated that items were treated and disposed 
of as biohazardous waste when the agent was infectious to humans.  Ninety-four percent 
of respondents indicated that waste regarded as infectious to animals was treated as 
biohazadous.  The lowest response category for biohazardous waste treatment was items 
infectious to plants with a 76% positive response.  Ninety-three percent of respondents 
indicated that recombinant DNA microorganism waste was regarded as biohazardous by 
their institution. 
FIGURE 5: Treatment of Cell Cultures as Biohazardous Waste (Category 2) 
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Ninety-eight percent of respondents indicated that human cell cultures regarded or 
known to be infectious were treated as biohazardous waste.  Non-infectious human 
cultures were also regarded as biohazardous by 84% of respondents.  Regarding animal 
cell cultures, 91 % of respondents indicated that these items were treated as biohazardous 37 
waste if known to be infectious and 65% indicated that non-infectious animal cell 
cultures were also treated as biohazardous waste.  Regarding plant cell cultures, 76% of 
respondents indicated that these items were treated as biohazardous waste while 42% 
indicated that non-infectious plant cell cultures were additionally regarded as 
biohazardous waste. 
The third category of wastes addressed in the waste definition question addressed 
wastes related to human body fluids and tissues. 
FIGURE 6: Human Tissues and Body Fluids Treated as Biohazardous Waste 
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Seventy-seven percent of respondents indicated that fixed human tissues were 
regarded as biohazardous wastes.  Unfixed tissues were treated as biohazardous by 97% 
of respondents.  Bulk blood and bulk blood products or other potentially infectious 
materials (OPIM) were treated as biohazardous waste by 88% and 92% of institutions 
respectively.  Items saturated with human blood or OPIM are managed as biohazardous 38 
wastes by 9] % of respondents.  Ninety-three percent of respondents indicated that body 
fluids other than blood or OIM are managed as biohazardous if the source is known to be 
infectious (i.e. isolation wastes).  These high percentages are the likely result of the 
strong influence of OSHA's Bloodborne Pathogen standard which was noted as a 
regulatory basis for biohazardous waste management policies by 93% of respondents. 
FIGURE 7: Animal Carcasses and Plant Wastes 
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Under Category 4 addressing animal research and diagnostic wastes, 95% of 
respondents indicated that animal carcasses, tissues and solid wastes generated in 
infectious disease research were treated as biohazardous waste under institutional 
policies.  Eighty-six percent of respondents indicated that the same types of items 
generated in recombinant DNA research were also regarded as biohazardous waste. 
Under Category 5 addressing plant materials using the same conditions mentioned in 
the animal research category, 72% of respondents indicated that plant materials and 
wastes generated in infectious disease research were treated as biohazardous.  Sixty-eight 
percent indicated that plant materials and wastes generated in recombinant DNA research 
were also treated as biohazardous waste. 39 
In addition to the waste categories listed in this question, respondents were asked to 
indicate whether other items not previously addressed were managed as biohazardous 
waste.  Twenty-three respondents (or 23%) indicated other wastes.  These responses are 
summarized in the following table. 
TABLE 3: Other Items Managed as Biohazardous Waste 
Category  Number of 
Responses 
All animal carcasses  I 
All microbiology wastes  4 
Biotoxins  3 
Chemotherapy agents  2 
Animal Blood/OPIM  1 
Clonal derivatives of human tissue  1 
Fixed animal tissues  1 
"Look-alike wastes"  6 
Pharmaceuticals  2 
Rodent carcasses and bird droppings  1 
Management of sharp items as biohazardous waste was also assessed. Because sharps 
present a puncture hazard and a disease transmission hazard, and are likely to raise public 
perception concerns, waste management decisions for these items may be variable.  This 
question was intended to examine which sharps are likely to be managed as a 
biohazardous waste regardless of contamination status.  Additionally, the question was 
intended to examine the contamination conditions that are likely to result in a sharp 
object being managed as a biohazardous waste if this is a factor. 40 
FIGURE 8: Sharp Items Disposed of As Biohazardous Sharps Waste 
(Regardless of Contamination Status) 
Type of Sharp Item 
Response rate for this question was 99%.  As shown in Figure 8, eighty-five percent 
of respondents indicated that all hypodermic needles and syringes with needles were 
managed as biohazardous sharps by their institutions regardless of contamination status. 
All syringes without needles were treated as biohazardous sharps by 54% of institutions. 
All scalpels and/or razor blades were managed as biohazardous sharps by 72% of 
institutions. 
Twenty-five percent of institutions indicated that all glass specimen tubes managed as 
biohazardous sharps regardless of contamination status.  All pasteur pipettes were 
managed as biohazardous sharps by 35% of institutions.  All capillary tubes were treated 
as biohazardous sharps by 28% of institutions.  Twenty-six percent of respondents 
indicated that all slides and cover slips were managed as biohazardous sharps.  Only 15% 41 
of institutions indicated that broken glass, regardless of contamination, was treated as 
biohazardous sharp material. 
Respondents were also asked to indicate under what specific conditions an item 
would be managed as a biohazardous sharp.  If  a respondent did not check the box 
indicating that all items in a category were managed as sharps regardless of 
contamination, their responses in the various contamination condition categories for each 
item were compiled for the two following figures.  The percentages reflected in the 
figures were tabulated by dividing the number of responses for the contamination 
category by number of total "conditional" responses for the item category, and 
multiplying this value by 100. 
FIGURE 9a: 
Conditional Treatment of Various Sharp Items as Biohazardous Waste 
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FIGURE 9b: 

Conditional Treatment of Various Sharp Items as Biohazardous Waste 
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As illustrated in Figures 9a and 9b, there was a common trend across the item 
categories regarding the contamination conditions that resulted in the items being treated 
as biohazardous sharps waste.  Therefore, rather than examine percentages for each item 
category and contamination condition, it is perhaps more useful to examine the effect of 
contamination status over all of the sharp item categories by averaging the percentage 
across each item category. 43 
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FIGURE 10: Average Percent of Sharps Treated as Biohazardous Waste 
Based on Contamination Condition 
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An average of 93% of "conditional" respondents indicating that sharp items were 
treated as biohazardous waste if they were contaminated with human blood.  An average 
of 95% of "conditional" respondents treated sharp items as biohazardous waste if the 
items were contaminated with material that was infectious to humans.  A 66% average of 
such responses indicated that sharps items contaminated with animal blood were 
managed as biohazardous sharps  by their institutions.  An average of 79% of 
"conditional" respondents indicated that sharp items contaminated with material 
infectious to animals were managed as biohazardous sharps.  An average of 56% of 
"conditional" respondents indicated that sharps contaminated with material infectious to 
plants were treated as biohazardous sharps.  Only an average of 26% of "conditional" 
respondents indicated that radioactively or chemically contaminated sharp materials were 
managed as biohazardous waste. 44 
Off-site Biohazardous Waste Treatment Methods 
The portion of biohazardous waste that is managed off-site by large research-based 
institutions was assessed. 
Figure 11: Portion of Biohazardous Waste 
Managed Through a Medical Waste Hauler 
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The response rate for this question was 100%.  As shown in Figure 11, thirteen 
percent of the respondents indicated that their institution did not use a licensed medical 
waste hauler (MWH) for management of any portion of its biohazardous waste stream. 
Thirteen percent of respondents indicated that between 1  % and 10% of their 
biohazardous waste was treated and disposed of through a licensed MWH.  Ten percent 
of responding institutions indicated that a licensed MWH was used for treatment and 
disposal of between I I % and 25% of their biohazardous waste stream.  Another 10% of 
respondents indicated that a licensed MWH was used for between 26% and 50% of their 
biohazardous waste.  Eight percent of respondents indicated that between 51 % and 75% 
of their biohazardous waste stream was managed through a licensed MWH.  Finally, 46% 
of respondents indicated that over 75% of their institution's biohazardous waste was 45 
treated and disposed of through a licensed MWH.  Of this last category, 57% of these 
institutions also indicated that they had an in-patient health care facility. 
On-Site Biohazardous Waste Treatment Methods 
The use of autoclaves, incineration and other forms of on-site waste treatment 
methods was determined.  Four questions in the survey pertained to the use of autoclaves, 
post-treatment disposal, and equipment performance criteria. 
Response rate for the question addressing use of autoclaves as a form of on-site 
treatment was  100%.  Ninety percent of the respondents indicated that autoclaves were 
used for this process in accordance with their institution's biohazardous waste policies. 
Of these 90 respondents, 85 indicated that waste generators treat their own waste in 
autoclaves located within their facility or building.  Twenty respondents indicated that 
waste was collected from waste-generating sites, then transported to a central location for 
treatment by waste management personnel. 
Respondents were also asked to indicate the various means by which waste was 
disposed of once treated by autoclave.  Of the 89 respondents for this question: 
• 	 67 (or 75%) indicated that waste was landfilled as non-hazardous waste; 
• 	 39 (or 44%) indicated that waste was incinerated; 
• 	 14 (or 1690) indicated "other" options with write-in responses including 
further management through a MWH and shredding. 
For those respondents using autoclaves for on-site biohazardous waste treatment, they 
were further asked to indicate how autoclave performance was validated, and with what 
frequency, to assure effective decontamination of waste. 
Of the 90 respondents who indicated that autoclaves were used for this purpose, 6 
respondents (7%) did not indicate that any form of formal validation testing procedures 46 
were in place.  All of these respondents had indicated that autoclaving of waste was 
performed independently by the waste generator in their research area. 
Regarding the institutions that indicated formal use of testing procedures, 53 used 
autoclave tape on each load.  Eight respondents indicated the use of tape at various other 
frequencies. 
As shown in Figure 12, more formal testing methods and frequencies were evident in 
the use of chemical indicator strips (chern-indicators) and Bacillus stearothermophilus 
ampoules (bio-indicators). 
FIGURE 12: Frequency and Type of Autoclave Performance Testing 
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Twelve respondents indicated that chern-indicators were used on each load.  One 
institution used the chern-indicator method daily.  Weekly testing using this method was 
indicated by 9 respondents.  Five respondents indicated that autoclaves were tested 47 
monthly by this method, and 2 respondents indicated that chem-indicators were used for 
annual testing. 
Regarding the use of bio-indicators, 2 respondents indicated that this test method was 
used for each load, and one respondent indicated that this method was used daily.  Six 
respondents indicated that bio-indicators are used for weekly testing. Monthly testing 
employing a bio-indicator was used by 23 institutions.  Four respondents indicated that 
this method is used quarterly.  Fourteen institutions used this test method for annual 
performance validation.  Two respondents indicated that this test method was used for 
validation after every 40 hours of autoclave use. 
Seven respondents indicated "other" testing methods.  Of these methods: 
•  4 were related to service contractor assessment; 
•  I institution used review of autoclave run logs; and 
•  2 institutions used B.  stearothermophilus indicator strips. 
Information was then collected regarding the use of on-site incineration as a waste 
treatment and disposal method.  The response rate for this group of questions was 100%. 
Forty-two respondents indicated that they had an on-site incinerator used for treatment 
and disposal of biohazardous waste.  Of those institutions with incinerators, 22 indicated 
that their incinerators were classified as medical/infectious waste incinerators as defined 
by the EPA regulations.  As anticipated, 12 of these respondents had indicated that their 
institutions have an  in-patient medical care facility that would result in  the generation of 
medical waste. 
The respondents who indicated that their incinerators were HMIWI's were further 
asked about their plans for compliance with the recent enactment of EPA's HMIWI 
regulations as shown in Figure 13. 48 
FIGURE 13: Compliance Plans for Institutions with HMIWl's 
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Of the 22 respondents to be affected by EPA's HMIWI regulations, 9 indicated that 
their current equipment and management systems would meet the requirements for that 
regulation.  One respondent indicated that the institution's equipment would be upgraded 
to meet regulatory requirements.  Three respondents indicated that their institution will 
discontinue incineration.  Eight responded that their institution's course of action 
regarding future incineration use has yet to be determined, and one respondent did not 
complete this portion of the question series. 
The use of other forms of on-site treatment for biohazardous waste was also assessed. 
Twenty-three respondents did not indicate that any additional forms of treatment were 
used by their insitution.  Seventy-two respondents indicated that chemical disinfection 
was used for some biohazardous waste treatment.  Four respondents indicated that 
irradiation was used.  Only one respondent noted an alternative technology described as 
"high water pressure grinding." 49 
Biohazardous Waste Management Program Compliance 
Information was collected regarding the control provisions of the institutions' 
biohazardous waste management programs.  Respondents were asked to identify the 
control provisions included in their current programs (Figure 14). 
FIGURE 14: Biohazardous Waste Management Plan Control Provisions 
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Response rate for this question varied between 97% and 99%, depending on the 
category.  Ninety-eight percent of respondents indicated that their programs included 
segregation and packaging requirements for biohazardous waste.  Training requirements 
for biohazardous waste generators were included in the provisions for 75% of the 
responding institutions.  Forty percent of respondents indicated that there were additional 
training requirements for personnel performing their own on-site waste treatment. 
Documentation to assure the proper treatment and final disposal of waste (i.e. 
"manifesting") was indicated as a requirement by 73% of respondents.  Eighty percent of 
respondents indicated that inspections of waste generating areas were used as a means of 
controlling compliance at their institutions.  Contingency plans for waste disposal were 50 
included as a provision by 70% of responding institutions, and emergency contacts were 
included as a provision by 77% of institutions. 
Respondents were also asked to write in additional provisions not previously 
included. Fourteen respondents indicated additional p~ovisions including procedural 
requirements imposed by the MWH or institution's maintenance departments, and 
research restrictions on violators. 
Finally, as shown in Figure 15, respondents were asked to identify the control 
provisions that were most critical to the effectiveness of their biohazardous waste 
management programs. 
FIGURE 15: Most Critical Provisions for Assuring Compliance with Policies 
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Response rate for this question was 89%, which may have been due to the fact that it 
was the last question on the survey.  Based on the responses collected, training 
requirements for waste generators (30%), segregation and packaging requirements (26%), 
and inspections (23%) appear to be the control provisions that are most critical to the 
success of biohazardous waste management programs at the responding institutions. 52 
CHAPTER 4 
DISCUSSION 
There were several important findings of this study.  Ninety-eight percent of 
respondents indicated that human celI cultures regarded or known to be infectious were 
treated as biohazardous waste, while non-infectious human celI cultures were regarded as 
biohazardous by 84% of respondents.  Human cell lines are considered to be potentialIy 
infectious materials in accordance with OSHA's Bloodborne Pathogens standard unless 
they are tested and determined to be virus-free (OSHA, 1994).  Ninety-three percent of 
respondents indicated that they based their biohazardous waste management plans on 
OSHA BBP requirements while only 84% of respondents are treating alI  human celI 
cultures as biohazardous waste.  This implies that 9% of respondents are either testing 
their celI lines to assure that they are virus-free or they are not managing these items 
properly for disposal. 
With respect to the treatment of human tissues and body fluids, all categories with the 
exception of fixed tissues were regarded as biohazardous waste by at least 88% of 
respondents.  This result was expected based on the fact that 93% of respondents 
indicated that they based their biohazardous waste management plans on OSHA 
requirements.  Interestingly, 77% of respondents indicated that they treat fixed human 
tissues as biohazardous waste, even though these tissues are not considered to be 
potentially infectious materials under the OSHA Bloodborne Pathogens standard (OSHA, 
1992).  This may be explained by the fact that 98% of respondents indicated that state 
environmental regulations were used as a basis for their biohazardous waste management 
plans.  State environmental regulations are often modeled after the  EPA Guidefor 
Infectious Waste Management (1986) which includes tissues, organs or body parts 
removed during surgery, autopsy or biopsy in its definition of pathological waste. 
Eighty-six percent of respondents indicated that they used CDCINlli guidelines in the 
development of their biohazardous waste policies.  Based on these findings, it is not 
surprising that 95% of respondents regarded animal carcasses generated in infectious 
disease research as biohazardous waste, and 86% of respondents regarded animal 53 
caracasses generated in recombinant DNA as biohazardous waste.  In contrast, under the 
plant waste category, 72% of respondents indicated that wastes generated in infectious 
disease research are regarded as biohazardous waste.  However, only 68% of respondents 
indicated that plant wastes generated from recombinant DNA research are treated as 
biohazardous wastes.  This response was lower than expected based on the 86% of 
respondents who indicated they used CDCINIH guidelines as a basis for their waste 
policies.  The fact that only 68% of respondents treat this waste as biohazardous may 
indicate an oversight of NIH requirements for conducting recombinant DNA plant 
research. 
Respondents were given the opportunity to write in other items that were not listed in 
the survey, but were also managed as biohazardous waste by their institutions.  Six 
indicated that biotoxins are managed as biohazardous waste.  This suggests an emerging 
issue involving the proper disposal of biotoxins and one that should be addressed in 
future research.  Public perception of waste is an evident consideration for institutions as 
indicated by the 6 respondents who indicated that "look-alike waste" (i.e. items that bear 
a resemblance to biohazardous waste like disposable gloves and pipette tips) is managed 
as biohazardous waste. 
Regarding the management of sharps as biohazardous waste, 3 particular items were 
consistently managed as a biohazardous waste regardless of their contamination status 
including: hypodermic needles (85%), syringes with needles (85%), and scalpels/blades 
(72%).  These items present a puncture hazard by design and are identified as sharps 
under the Bloodborne Pathogens standard if biologically contaminated (OSHA, 1992). 
Syringes with needles and hypodermic needles are also commonly associated with 
mismanagement of medical waste as demonstrated in beach wash-up incidents (NY 
Times,  1998; Turnberg, 1996).  Therefore, the unconditional treatment of these items as 
biohazardous waste may be the result of OSHA requirements as well as prudent practice 
to eliminate public perception concerns.  Syringes without needles attached were 
managed unconditionally as biohazardous waste by 54% of respondents.  This finding 
may be the result of state environmental regulations that may be more restrictive on the 
definition, management and disposal of biohazardous wastes (Waste Age/Infectious 
Waste NeVl's,1998). 54 
Waste treatment methods used by large, research-based universities included 
incineration, steam sterilization by autoclave and management through a licensed medical 
waste hauler (MWH).  Surprisingly, 46% of the universities were using a MWH for 
management of over 75% of their biohazardous waste stream.  This indicates a growing 
market sector for the MWH industry. 
Regarding on-site waste treatment methods, 90% of respondents indicated that they 
were using autoclaves for treatment of biohazardous waste.  Seventy-five percent 
indicated that their waste was being landfilled as non-hazardous waste following this 
treatment.  Yet, only 47 of the 90 (52%) institutions using autoclaves for this purpose 
indicated validation of their decontamination process using a biological indicator 
(8. stearother11lophilus) with any frequency.  The Model Guidelines for State Medical 
Waste Management (Council of State Governments, 1992) recommends the biological 
indicator method for validating autoclave performance over other methods and further 
recommends testing after every forty hours of use.  Eight (9%) respondents indicated 
using this validation method on a weekly or less frequent basis.  Twenty-three (26%) 
indicated monthly testing, 4 (4%) indicated quarterly testing, and 14 (16%) indicated 
annual testing.  This variability in testing frequency may be the result of individual state 
regulatory requirements for this process or indicate a general weakness in validation 
process. 
Importantly, results of this study indicate that nearly 50% (10 out of 22) of HMIWI's 
used in the large research-based university environment will continue to operate in light 
of stricter EPA regulations.  This is a contrast to the statistics that project that more than 
80% of incinerators will cease to operate under stricter regulations (Brunner, 1996). 
Only 3 out of 22 (14%) respondents that indicated their institution currently used an 
HMIWI said that they would be discontinuing this form of treatment, and eight (36%) 
respondents indicated that actions were yet to be determined. 
The most common control provision for compliance with biohazardous waste 
management plans was segregation and packaging.  Due to the nature of biohazardous 
materials (contaminated sharp materials, potentially infectious liquid materials) 
segregation and packaging are basic requirements of many of the regulations that would 
affect virtually all generators including the OSHA Bloodborne Pathogens standard, state 55 
environmental regulations, and DOT requirements for transportation of hazardous wastes. 
Thus, the high percentage of respondents noting control provision was expected.  The 
least noted control provision was additional training for waste treatment (40%). 
Although about half of the universities (46%) indicated that they are using a medical 
waste hauler for management of over 75% of their biohazardous waste stream, 90% of 
universities responded that they use autoclaves for treatment of waste.  Of those 90 
respondents, 85 indicated that generators treat their own waste in autoclaves located 
within their facility.  This data indicates that a large proportion (roughly 50%) of 
personnel who are treating their own waste by autoclave may not be receiving training in 
the effective and safe techniques required for this process.  Surprisingly, when asked to 
indicate which control provisions were found to be most critical for assuring compliance 
with policies, only 2% of respondents indicated that additional training for those who 
treat their own waste was a critical provision. 56 
CHAPTERS 
CONCLUSIONS AND RECOMMENDATIONS 
Findings of this study indicate that biohazardous waste management programs in 
large, research-based universities are highly variable in some respects, but all have some 
common underlying qualities that drive their programs. 
Virtually all universities indicated that they are conducting biotechnology and BL2 
level research while less than half indicated that their university had an in-patient 
healthcare facility.  Results of this study demonstrate that biohazardous waste 
management in large research-based universities can not rely solely on policies and 
regulations addressing only medical waste.  This was reflected through the most 
frequently cited regulations and guidelines used as the basis waste management 
programs- state, OSHA Bloodborne Pathogens standard, and CDClNrrI guidelines. 
Compliance with regulations and recommendations related to research was 
investigated in  this study.  All items that were potentially infectious to humans were 
treated as biohazardous waste as required under OSHA's Bloodborne Pathogens 
standard.  The vast majority of respondents relied on this standard as a basis for program 
development.  Items contaminated with animal blood or potentially infectious to animals 
were also regarded as biohazardous waste by the majority of institutions.  In contrast, 
items potentially infectious to plants were the least likely to be treated as a biohazardous 
waste, indicating that more attention may need to be given to this category of waste. 
The scope of the research presented here was limited to examining general 
information regarding biohazardous waste management in the large, research-based 
universities in the U.S.  The study did not include quantification of the waste stream. 
Further studies should be conducted to examine the quantity of biohazardous waste 57 
generated in these environments in order to assess the need for developing waste 
treatment alternatives for this environment.  As biohazardous waste treatment and 
disposal becomes more complex and costly, there will be a growing need for examination 
of alternative technologies by the large, research-based university.  This study provides 
valuable information for universities in general regarding the topic.  However, it is not 
directly applicable to universities outside the U.S. or to small and medium universities. 
Similar research adapted to small or medium universities may be especially beneficial to 
these institutions.  EHS personnel responsible for biohazardous waste management at 
institutions of this size are likely to be dealing with multiple EHS programs and may not 
necessarily have the time or resources required to develop a comprehensive biohazardous 
waste management program. 
Recommendations for Biohazardous Waste Program Development 
Based on the findings of this study, the following recommendations can be made to 
EHS staff or biosafety personnel regarding biohazardous waste program development: 
I. 	 Identify business operations and research activities at the university that are likely 
to result in biohazardous waste generation.  Research applicable regulations and 
guidelines pertinent to these business operations and activities and integrate these 
requirements in the management plan. 
2. 	 Assess waste treatment techniques to assure that waste is treated in the safest, and 
most cost-effective manner.  In situations where waste generation is limited, 
management through a MWH may be the best alternative. 
3. 	 Periodically review the effectiveness of treatment techniques and stay current 
with technological and regulatory developments in this area. New treatment 
methods that are cost-justifiable are likely to be developed as regulations over 
treatment techniques become more restrictive. 58 
4. 	 Regardless of the waste disposal method chosen, include provisions for 
segregation and packaging, training, and inspections of waste generating areas as 
a minimum to assure compliance with OSHA and state environmental regulations. 
5. 	 Use guidance documents such as the EPA Guide for Infectious Waste 
Management and the Model Guidelines for State Medical Waste Management to 
develop biohazardous waste management programs.  Although these documents 
are dated in their technological information, they contain valuable information 
about program development and waste handling practices that are not restricted to 
the medical waste portion of the biohazardous waste stream. 59 
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Appendix A 
Carnegie Classification Research I & II Universities 64 
Carnegie Classification Research I Universities (Page 1 of 3) 
University 
University of Alabama-Birmingham 
Arizona State University-Main 
University of Arizona 
University of California-Santa Barbara 
California Institute of Technology 
Stanford University 
University of California-Berkeley 
University of California-Davis 
University of California-Irvine 
University of California-Los Angeles 
University of California-San Diego 
University of California-San Francisco 
University of Southern California 
Colorado State University 
University of Colorado-Boulder 
University of Connecticut 
Yale University 
Howard University 
Georgetown University 
Florida State University 
University of Florida 
University of Miami 
Emory University 
Georgia Institute of Technology 
University of Georgia 
University of Hawaii-Manoa 
Iowa State University 
University of Iowa 
University of Illinois-Chicago 
University of Illinois-Urbana Champaign 
Northwestern University 
University of Chicago 
Indiana U ni versity-Bloomington 
Purdue University 
University of Kansas-Main 
University of Kentucky 
Louisiana State University 
Tulane University 
Boston University 
Tufts University 
City  State 
Birmingham  AL 
Tempe  AZ 
Tucson  AZ 
Santa Barbara  CA 
Pasadena  CA 
Stanford  CA 
Berkeley  CA 
Davis  CA 
City of Irvine  CA 
Manhatten Beach  CA 
La Jolla  CA 
San Francisco  CA 
Los Angeles  CA 
Fort Collins  CO 
Boulder  CO 
Storrs  CT 
New Haven  CT 
Washington  DC 
Washington  DC 
Tallahassee  FL 
Gainesville  FL 
Miami  FL 
Atlanta  GA 
Atlanta  GA 
Athens  GA 
Honolulu  HI 
Ames  IA 
Iowa City  IA 
Chicago  IL 
Urbana  IL 
Evanston  IL 
Chicago  IL 
Bloomington  IN 
West Lafayette  IN 
Lawrence  KS 
Lexington  KY 
Baton Rouge  LA 
New Orleans  LA 
Boston  MA 
Boston  MA 65 
Carnegie Classification Research I Universities (Page 2 of 3) 
Universitv 
Harvard University 
University of Massachusetts 
Massachusetts Institute of Technology 
Johns Hopkins University 
University of Maryland-College Park 
Michigan State University 
University of Michigan 
Wayne State University 
University of Minnesota-Twin Cities 
University of Missouri-Columbia 
Washington University 
University of Nebraska-Lincoln 
North Carolina State University 
University of North Carolina-Chapel Hill 
Duke University 
Princeton University 
Rutgers University 
University of New Mexico 
New Mexico State University-Main 
Cornell University 
New York University 
Rockefeller University 
State University of New York-Buffalo 
State University of New York-Stony Brook 
University of Rochester 
Columbia University-City of New York 
Case Western Reserve University 
Ohio State University-Main 
University of Cincinnati-Main 
Oregon State University 
Carnegie Mellon University 
Penn State-University Park 
Temple University 
University of Pennsylvania 
University of Pittsburgh-Pittsburgh 
Brown University 
University of Tennessee-Knoxville 
Vanderbilt University 
Texas A&M University 
University of Texas-Austin 
Utah State University 
University of Utah 
City  State 
Boston  MA 
Amherst  MA 
Cambridge  MA 
Baltimore  MD 
College Park  MD 
East Lansing  MI 
Ann Arbor  MI 
Detroit  MI 
Minneapolis  MN 
Columbia  MO 
St. Louis  MO 
Lincoln  NB 
Raleigh  NC 
Chapel Hill  NC 
Durham  NC 
Princeton  NJ 
Piscataway  NJ 
Albuquerque  NM 
Las Cruces  NM 
Ithaca  NY 
New York  NY 
New York  NY 
Buffalo  NY 
Stony Brook  NY 
Rochester  NY 
New York  NY 
Cleveland  OH 
Columbus  OH 
Cincinnati  OH 
Corvallis  OR 
Pittsburgh  PA 
University Park  PA 
Philadelphia  PA 
Philadelphia  PA 
Pittsburgh  PA 
Providence  RI 
Knoxville  TN 
Nashville  TN 
College Station  TX 
Austin  TX 
Logan  UT 
Salt Lake City  UT 66 
Carnegie Classification Research I Universities (Page 3 of 3) 
University 
University of Virginia 
Virginia Commonwealth University 
Virginia Polytechnic & State University 
Uni versity of Washington-Seattle 
University of Wisconsin-Madison 
West Virginia University 
City 
Charlottesville 
Richmond 
Blacksburg 
Seattle 
Madison 
Morgantown 
State 
VA 
VA 
VA 
WA 
WI 
WV 67 
Carnegie Classification Research II Universities (Page 1 of 1) 
University 
University of Arkansas 
University of California-Santa Cruz 
University of California-Riverside 
George Washington University 
University of Delaware 
University of South Florida 
University of Idaho 
Southern Illinois University-Carbondale 
University of Notre Dame 
Kansas State University 
University of Louisville 
Brandeis University 
Northeastern University 
Mississippi State University 
University of Mississippi 
Saint Louis University 
Rensselaer Polytechnic Institute 
Syracuse University-Main 
State University of New York-Albany 
Kent State University-Main 
Ohio University-Main 
Oklahoma State University-Main 
Uiversity of Oklahoma-Norman 
University of Oregon 
University of Rhode Island 
Clemson University 
University of South Carolina-Columbia 
Rice University 
University of Houston 
Brigham Young University 
University of Vermont 
Washington State University 
University of Wisconsin-Milwaukee 
University of Wyoming 
City  State 
Fayetteville  AR 
Santa Cruz  CA 
Riverside  CA 
Washington  DC 
Newark  DE 
Tampa  FL 
Moscow  ID 
Carbondale  IL 
Notre Dame  IN 
Manhatten  KS 
Louisville  KY 
Waltham  MA 
Boston  MA 
Mississippi State  MS 
University  MS 
St. Louis  MO 
Troy  NY 
Syracuse  NY 
Albany  NY 
Kent  OH 
Athens  OH 
Stillwater  OK 
Norman  OK 
Eugene  OR 
Kingston  RI 
Clemson  SC 
Columbia  SC 
Houston  TX 
Houston  TX 
Provo  UT 
Burlington  VT 
Pullman  WA 
Milwaukee  WI 
Laramie  WY 68 
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First Contact Phone Script 
The following script was used when first contact was made with universities and survey 
respondents were identified. Highlighted portions of the script indicate the essential 
information that was conveyed in all contact cases to solicit participation and satisfy 
human subjects regulatory requirements. 
Hello.  My name is Robin Mecklem.  I am the Assistant Biological Safety Officer for Michigan 
State University.  I am also a graduate student in the Environmental Health Management program 
of Oregon State University and am in the process of completing my master's degree thesis.  To 
complete my thesis, I am planning to conduct a survey of environmental health and safety 
professionals at large, research-based universities in the United States.  This survey is regarding 
biohazardous waste management practices used by such universities.  Although many studies 
have been conducted regarding biohazardous waste management practices, little research has 
been conducted specifically addressing biohazardous waste in the university research setting. 
The results of this study will provide valuable insight regarding the definition, treatment, and 
disposal of waste in this setting and serve as a resource for other universities who are developing 
biohazardous waste management programs. 
I received your name from your university's web site (or environmental health and safety 
director) and believe that you may be the person who is most knowledgeable of biohazardous 
waste practices at your institution.  Is this correct?  (If the reply is No- Can you refer me to the 
person who you believe would be most knowledgeable?) 
May I tell you a few details about the survey?  I plan to mail the survey to participants in early 
September 1999.  The survey is 2 and one-half pages long with 14 to 16 questions- most of which 
can be answered by checking the appropriate box.  This survey should not take more than  15 
minutes to complete based on trial runs.  I will be asking respondents to return the survey within 
30 days of receipt.  A self-addressed stamped envelope will be provided for the return of the 
survey.  The survey does not require any information that identifies respondents or institutions. 
Surveys will be identified only by number for followup of those respondents who do not return 
their survey within 30 days.  These numbers will be removed upon return receipt and prior to data 
analysis. 
Would you be willing to participate in this survey?  (If No- Is there someone else at your 
institution who is also knowledgeable of your institution's biohazardous waste practices that I can 
contact?) 
Great.  Can I verify that my mailing information for you is correct? 
Thank you.  You should receive your survey packet in mid-September with a summary of the 
information that I have told you today.  However, I would like to give you my name and number 
again in case you have any further questions.  I am Robin Mecklem and I can be reached at 517­
355-1283.  My research advisor for the survey can also answer any questions you may have.  She 
is Dr. Cathy Neumann in the OSU Department of Public Health.  Her phone number is 541-737­
3833.  Do you have any further questions at this time? 70 
Survey Cover Letter 
September 15,  1999 
To: 	<Name>, <Institution> 
A short time ago, you were contacted and asked to participate in a survey regarding biohazardous 
waste management practices used by your institution. This survey is part of a Master's thesis 
being completed through the Oregon State University Department of Public Health. 
Biohazardous waste management presents a number of challenges in the research-based 
university environment.  This is due to the broad range of research activities that may result in 
the generation of this waste, as well as the diverse range of regulations that may apply to that 
research.  To date, the question of biohazardous waste management in the large research 
university environment has been virtually unexamined.  Through the administration of the 
attached survey, we hope to address the following questions: 
I. 	 Which regulations and/or guidelines are used to define biohazardous waste and to determine 
proper treatment and disposal? 
2. 	 What are the most common methods of treatment and disposal for biohazardous waste? 
3. 	 What control measures are used to assure safe and proper handling, treatment and disposal of 
biohazardous waste? 
In  addition to identifying common trends in biohazardous waste management practices, the data 
will be used to develop an effective model biohazardous waste management plan for research­
based universities. 
Please complete the enclosed survey within 30 days, and return it in the self-addressed stamped 
envelope provided in the survey packet.  Please be assured that confidentiality of all responses 
will be maintained by the research team.  Your survey is identified by a number which will be 
removed upon receipt and prior to data analysis.  This number will only be used to identify and 
follow up with individuals who do not return a completed survey. 
If you have any questions regarding this study please feel free to contact me at (517) 355-1283 or 
Dr. Cathy Neumann at (541) 737-3833.  To receive a summary of the results of this study, please 
e-mail me at mecklem@pilot.msu.edu.  If you do not have e-mail, please fax your request to me 
at (517) 353-4871. 
Sincerely, 
Robin Lyn Mecklem  Cathy Neumann, Ph.D. 
Graduate Candidate  Assistant Professor 
Environmental Health Program  Environmental Health Program 
Department of Public Health  Department of Public Health 
Oregon State University  Oregon State University 
Corvallis. Oregon 97331  Corvallis, Oregon 97331 71 
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Survey Tool 72 
Defining and Managing 
Biohazardous Waste in 
Research-Based Universities 
in tile United States: 
A Survey ofEnvirOlll1lelltal 
Health and Safety Professiollals 
Please return your completed survey in the envelope 
provided to: 
Robin Mecklem 

OSU Graduate Candidate 

P.O. Box 261 

Mason, MI 48854 
73 
Defining and Managing 
Biohazardous Waste in 
Research-Based Universities 
in the United States 
Instructions for the Respondent: 
Before proceeding with the enclosed survey, please take a moment to review the definitions 
below which will assist you in completing the survey. 
Biohazardous Waste:  Waste that is potentially infectious to living organisms.  It may 
(depending on your local and state deifinitions) encompass medical waste as defined by 
occupational safety regulations and state waste regulations, as well as wastes generated in 
plant or animal research which are potentially infectious to these organisms, or may alter their 
natural genetic selection process.  Any waste that requires segregation and specific treatment 
separate from the municipal waste stream due to its true or perceived infectious quality. 
Commonly Used Abbreviations 
EPA:  Environmental Protection Agency 
OSHA:  Occupational Safety and Health Administration 
CDC:  Centers for Disease Control 
NIH:  National Institutes of Health 
USDA:  United State Department of Agriculture 
APHIS:  Animal and Plant Health Inspection Service 
lCAHO:  loint Commission on Accreditation of Healthcare Organizations 
AAALAC:  Association For Assessment and Accreditation of Laboratory Animal Care 
USDOT:  United States Department of Transportation 
OPIM:  Other potentially infectious materials as defined by the OSHA Bloodborne 
Pathogens Standard 
Please complete all applicable questions as outlined throughout the survey. 74 
Institution Profile 
I. 	 What kind of facilities or activities are generating biohazardous waste at your institution?  (Please 
circle NO or YES for all categories.) 
Facilities!Activities 
a.  Does your institution have an in-patient medical treatment facility (i.e. hospital) 
on campus? 
NO  YES 
b.  Does your institution have a veterinary medicine school which performs 
teaching, treatment and research? 
NO  YES 
c.  Is biotechnology research (i.e. recombinant DNA, human gene therapy, 
transgenics) currently conducted at your institution? 
NO  YES 
d.  Is Biosafety Level 2 research currently conducted at your institution?  NO  YES 
e.  Does your institution have a Biosafety Level 3 research facility currently in use?  NO  YES 
Biohazardous Waste Management Procedure Development 
2. 	 Which agency definitions, guidelines or regulations were used to develop your institution's 
biohazardous waste management procedures? (PLease circle NO or YES for all categories.) 
Agency 
a.  EPA Regulations (e.g. Medical Waste Tracking Act)  NO  YES 
b.  Local Waste Regulations (e.g. Publicly Owned Treatment Works)  NO  YES 
c.  State Waste Regulations  NO  YES 
d.  OSHA Regulations (e.g. Bloodbome Pathogens Standard)  NO  YES 
e.  CDClNIH Guidelines (e.g."Biosafety in Microbiological and Biomedical 
Laboratories") 
NO  YES 
f.  USDNAPHIS Regulations (e.g. "Introduction of Regulated Articles"; 
7CFR340) 
NO  YES 
g.  Accreditation Agency Requirements (e.g. JCAHO, AAALAC)  NO  YES 
h.  USDOT Regulations (e.g.49CFRI71-180)  NO  YES 
i.  Other: 
(Please write ill respollse ifapplicable.) 
NO  YES 
3. 	 Who has primary responsibility for the development and maintenance of your institution's 
biohazardous waste management procedures? (Please check one box.) 
o 	Biological Safety Officer 
o 	Biological Safety Committee 
o 	Hazardous Waste Specialist 
o 	Other:_________________ 
(Please wrile ill respollse ifapplicable.) 
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Defining Biohazardous Waste 
4. 	 Which of the following items (excluding sharps) are treated and disposed of as biohazardous waste in 
accordance with you institution's biohazardous waste management procedures?  (Please circle NO or 
YES for each item in each category listed below.) 
Cultures and stocks of infectious agents (and items contaminated with these) 
a.  agents infectious to humans  NO  YES 
b.  agents infectious to animals  NO  YES 
c.  agents infectious to plants  NO  YES 
d.  microorganisms constructed with recombinant DNA  NO  YES 
Cell Cultures 
a.  hurnan- noninfectious  NO  YES 
b.  human- infectious  NO  YES 
c.  animal- noninfectious  NO  YES 
d.  animal- infectious  NO  YES 
e.  plant- noninfectious  NO  YES 
f.  plant -infectious  NO  YES 
Human Tissues, Human Blood and Body Fluids 
a.  human tissues-fixed  NO  YES 
b.  human tissues-unfixed  NO  YES 
c.  bulk human blood  NO  YES 
d.  bulk human blood productS/OPIM  NO  YES 
e.  items saturated with human blood /OPIM  NO  YES 
f.  human body fluids other than blood/OPIM if  source infectious  NO  YES 
Animal Research and Diagnostic Wastes 
a.  animal carcassesltissues and solid wastes (i.e. bedding) generated in 
infectious disease research 
NO  YES 
b.  animal carcasses/tissues generated in recombinant DNA research  NO  YES 
Plant Materials 
a.  plant waste material generated in infectious disease research  NO  YES 
b.  plant waste material generated in recombinant DNA research  NO  YES 
5. 	 Does your institution regard any items other than those listed in Question 4 (and excluding sharps) as 
biohazardous waste? 
o 	No 
o 	Yes, these items are:_____________________________ 
(Please write in  response ifapplicable.) 
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6. 	 Under what conditions are the following items treated and disposed of as biohazardous sharps waste 
according to your institution's biohazardous waste management procedures?  (Please place an "X" in 
the appropiate boxes for each "sharp" listed in the 2 tables below.) 
Contamination status  Hypodermic 
needles 
Syringes with 
needles 
Syringes 
without needles 
Scalpels/razor 
blades 
All items in this category regardless of 
contamination status 
If contaminated with human 
blood/OPIM 
Ifcontaminated with agents infectious 
to humans 
If contaminated with animal 
blood 
If contaminated with agents infectious 
to animals 
If contaminated with agents infectious 
to plants 
If trace contaminated with radioactive 
or chemical waste 
Contamination status  Glass 
specimen 
tubes 
Pasteur 
pipettes 
Capillary 
tubes 
Slides and 
cover slips 
Broken glass 
All  items in this category 
regardless of contamination 
status 
If contaminated with human 
blood/OPIM 
If contaminated with agents 
infectious to humans 
If contaminated with animal 
blood 
If contaminated with agents 
infectious to animals 
If contaminated with agents 
infectious to~Iants 
If trace contaminated with 
radioactive or chemical waste 
lliohazardous Waste Treatment Methods-Offsite 
7. 	 What portion of your biohazardous waste is treated and disposed of by a licensed medical waste 
hauler"' 
o  0% (My institution does not use a licensed medical waste hauler at this time.) 
o  Between 1% and 10% 
o  Between  II % and 25% 
o  Between 26% and 50% 
o  Between 51 % and 75% 
o 	 Greater than 75% 
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Biohazardous Waste Treatment Methods-Onsite 
8. 	 Does your institution use decontamination by steam sterilizer (i.e. autoclave) as a form of on-site 
biohazardous waste treatment? 
o 	NO (Please proceed to Question 12.) 
o 	YES (Please proceed to Question 9.) 
9. 	 Where and how is decontamination by autoclave performed? (Please check all boxes tlull apply.) 
o 	 Biohazardous waste generators treat their own autoclavable waste using autoclaves located at 
their facility. 
o 	 Autoclave waste is collected from labs, clinical environments or other waste-generating 
facilities, then transported to central location for treatment by waste management personnel.  o 	 Other:__________________________ 
(Please write in response ifapplicable.) 
10. Once decontaminated by autoclave, how is waste managed? (Please check all boxes that apply.) 
o 	 Landfilled as nonhazardous waste 
o 	 Incineration  o 	 Other:___________________________ 
(Please write in response ifapplicable.) 
II. How frequently are autoclaves that are used for biohazardous waste treatment tested for effective 
destruction of microorganisms, and what test method is used?  (Please place an "X" in all boxes that 
apply in the table below.  Please write in responses where appropriate.) 
Testing Method  Each 
Load 
Daily  Weekly  Monthly  Quarterly  Annually  Other 
(please write in 
frequency) 
Autoclave tape 
Chemical indicator 
strip 
Bacillus 
stearothermophilus 
ampoule 
Other 
(Please write in 
method) 
12. Does your institution currently use an onsite incinerator to burn biohazardous waste? 
o  NO (Please proceed to Questioll /4.) 

DYES (Please proceed to Question /3.) 

Page 4 or 6 78 
13. Is your incinerator a medical waste incinerator as defined by EPA regulations (4OCFR part 60)? 
o 	NO (Please proceed to Question 14.) 
o 	YES (Please proceed to Question l3.a.) 
I 
13.a.  How will your institution comply with EPA's Medical Waste Incinerator Requirements? 
o  Current equipment and operating procedures will meet regulatory requirements 
o  Upgrade existing equipment and operating procedures to meet regulatory requirements 
o  Discontinue incineration 
o  Yet to be determined 
14. What other forms of on-site biohazardous waste treatment are used at your institution? (Please check 
all boxes that apply.) 
o  Chemical disinfection 
o  Irradiation  o  Other:____________________________________________________ 
(Please write in  response ifapplicable.) 
Biohazardous Waste Management Procedure Compliance 
15. Which of the following administrative controls are included as part of your institution's biohazardous 
wa~te management policies and procedures? (Please circle NO or YES for all categories.) 
Administrative Controls 
a.  Requirements for segregation, packaging & storage of biohazardous waste  NO  YES 
b.  Training requirements for waste generators  NO  YES 
c.  Additional training requirements for personnel performing their own onsite waste  NO  YES 
treatment 
d.  Documentation requirements to assure proper treatment and final disposal  NO  YES 
(i.e. "manifesting") 
e.  Periodic inspections of waste generating and treatment areas  NO  YES 
f.  Contingency plans for waste treatment and disposal  NO  YES 
g.  Designated emergency contacts for waste storage areas and waste treatment facilities  NO  YES 
16. 	Does your institution use any administrative controls other than those listed in  Question 15  to assure 
compliance with biohazardous waste policies and procedures? 
o 	No 
o 	Yes, these are:-::-_______--:-_-::--::---:-_______________ 
(Please write in  response ifapplicable.) 
17. Of the administrative controls that you have identified as being used by your institution in Question 15 
and 16, which 2 are most critical for assuring that biohazardous waste generators comply with disposal 
policies?  (Please list these 2 controls ill the space below.) 
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This concludes the survey questions.  Please use the space below to share comments that you may 
have regarding the survey. 
Thank you for your help! 

Please return your completed survey in the envelope provided to: 

Robin Mecklem- Graduate Candidate 

P.O. Box 261 
Mason, MI48854 
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2117 Medford Road #20 
Ann Arbor, MI 48104 
June 21, 1999 
Dear Robin Mecklem: 
I am writing this letter to give you a permission to use my survey, entitle "Medical 
Waste Treatment and Disposal Methods Used by Hospitals in Oregon, Washington, 
and Idaho" in your research. 
I would appreciate if  you acknowledge my survey in your proposal or subsequent 
publication. 
SinCejlY,  ./ 
jG~!i,-
Pom..(ipa Klangsin 82 
Permission Letter from Waste AgelInfectious Waste News 
You have our permission to use the material you requested (below) in the form you outlined. 
Please credit the publication and date in your footnotes or appendix. If you have any questions, 
please let me know. 
Bill Wolpin 
Editorial Director 
Waste Age 
6151  Powers Ferry Road, Suite 200 
Atlanta, GA 30339 
(770) 618-0112 
Fax: (770) 618-0349 
E-mail: billwolpin@intertec.com 
www.wastca!.!c.conmow . 
Subject: Permission to use copyrighted information 
From:  "Robin Lyn Mecklem" <SMTP:mecklem@pilot.msu.cdu> at OverlandPark 
Date:  1/4/2000  4:15 PM 
Mr. Wolpin: 
I am writing to request permission to cite information from "Infectious Waste News", Volume 13, 
No.  12 (June 8,  1998).  I am writing my Master of Science thesis regarding definition and 
management of biohazardous waste in large research-based universities in the U.S. and wish to 
include information from the publication listed above as part of my introduction or literature 
review chapter.  The information that I wish to use would be limited to the summarized 
information on state medical waste regulations that appears in the tables shown on page 2 & page 
3 of the publication listed above.  I do not plan to 
reproduce the tables but instead wish to only use the number of yes or no responses for 
several of the categories listed. 
Thank you for your consideration of this request and I look forward to your response. 
Robin Lyn Mecklem 
Graduate Candidate 
Oregon State University 
Robin Lyn Mecklem 
Assistant Biological Safety Officer 
MSU Office of Radiation, Chemical and Biological Safety 
C-124 Engineering Research Complex 
East Lansing, MI  48824 
Phone: 517-355-1283 
Fax:  517-353-4871 
Pager:  517-232-0443  mecklem@piloLmsu.edu 